앱토럼 그룹(APM)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.70 (+0.00%), 시가총액 $6.84M.
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
앱토럼 그룹의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
앱토럼 그룹의 현재 주가는 $0.70 (+0.00%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
앱토럼 그룹의 시가총액은 약 $6.84M입니다.
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and…